GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Silva Pharmaceuticals Ltd (DHA:SILVAPHL) » Definitions » PEG Ratio

Silva Pharmaceuticals (DHA:SILVAPHL) PEG Ratio : N/A (As of Mar. 02, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Silva Pharmaceuticals PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Silva Pharmaceuticals's PE Ratio without NRI is . Silva Pharmaceuticals's 5-Year EBITDA growth rate is 0.00%. Therefore, Silva Pharmaceuticals's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Silva Pharmaceuticals's PEG Ratio or its related term are showing as below:



DHA:SILVAPHL's PEG Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.67
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Silva Pharmaceuticals PEG Ratio Historical Data

The historical data trend for Silva Pharmaceuticals's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Silva Pharmaceuticals PEG Ratio Chart

Silva Pharmaceuticals Annual Data
Trend
PEG Ratio

Silva Pharmaceuticals Semi-Annual Data
PEG Ratio

Competitive Comparison of Silva Pharmaceuticals's PEG Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Silva Pharmaceuticals's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Silva Pharmaceuticals's PEG Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Silva Pharmaceuticals's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Silva Pharmaceuticals's PEG Ratio falls into.



Silva Pharmaceuticals PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Silva Pharmaceuticals's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


Silva Pharmaceuticals  (DHA:SILVAPHL) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Silva Pharmaceuticals PEG Ratio Related Terms

Thank you for viewing the detailed overview of Silva Pharmaceuticals's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Silva Pharmaceuticals Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Road No 8/A New, House No 65, Dhanmondi, Dhaka, BGD, 1209
Silva Pharmaceuticals Ltd is engaged in the manufacturing and marketing of pharmaceuticals finished products. The products are manufactured in the categories of Antibiotics, Analgesics, Antidiabetics, Narcotics, Anti pyretic, Antiinflammatory Drugs, Anti ulcerates, Antiemetic, Gastroprokinetic, Antihistamine, Antispasmodic expectorants, Vitamins, and Minerals medicines. The products are sold in the local market of Bangladesh.

Silva Pharmaceuticals Headlines

No Headlines